We are live on ! Find out more
CWG

C WorldWide Group Portfolio holdings

AUM $4.66B
1-Year Est. Return 11.67%
This Fund
S&P 500
This Quarter Est. Return
+5.2%
1 Year Est. Return
+11.67%
3 Year Est. Return
+62.16%
5 Year Est. Return
+69.96%
10 Year Est. Return
+372.2%
AUM
$6.92B
AUM Growth
-$118M
Cap. Flow
-$387M
Cap. Flow %
-5.59%
Top 10 Hldgs %
73.6%
Holding
128
New
2
Increased
25
Reduced
68
Closed
5

Top Buys

Rank Stock Value
1
V icon
Visa
V
+$13.6M
2
C icon
Citigroup
C
+$10.3M
3
ECL icon
Ecolab
ECL
+$9.75M
4
AMZN icon
Amazon
AMZN
+$8.59M
5
HD icon
Home Depot
HD
+$8.35M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$300M
2
META icon
Meta Platforms (Facebook)
META
+$53.9M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$42.9M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$12.5M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$5.74M

Sector Composition

Rank Sector Weight
1 Financials 30.75%
2 Consumer Discretionary 19.53%
3 Communication Services 15.03%
4 Healthcare 13.85%
5 Materials 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNA icon
76
Snap-on
SNA
$21.5B
$2.7M 0.04%
15,507
– –
SUPN icon
77
Supernus Pharmaceuticals
SUPN
$2.7B
$2.61M 0.04%
65,600
-5,543
-8% -$219K
ONCE
78
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.47M 0.04%
48,051
-4,298
-8% -$309K
HRTX icon
79
Heron Therapeutics
HRTX
$93.4M
$2.38M 0.03%
131,600
+31,600
+32% +$515K
AQN icon
80
Algonquin Power & Utilities
AQN
$4.59B
$2.36M 0.03%
167,900
– –
ACRS icon
81
Aclaris Therapeutics
ACRS
$715M
$2.19M 0.03%
88,600
-7,700
-8% -$188K
PBYI icon
82
Puma Biotechnology
PBYI
$398M
$2.16M 0.03%
21,856
-1,936
-8% -$217K
OXFD
83
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$2.15M 0.03%
153,900
-29,335
-16% -$430K
NEO icon
84
NeoGenomics
NEO
$1.99B
$2M 0.03%
225,600
-18,700
-8% -$172K
AFAM
85
DELISTED
Almost Family Inc
AFAM
$1.94M 0.03%
35,100
-3,100
-8% -$165K
EGRX
86
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.94M 0.03%
36,327
-27,715
-43% -$1.54M
INGR icon
87
Ingredion
INGR
$6.42B
$1.92M 0.03%
13,700
– –
ACHC icon
88
Acadia Healthcare
ACHC
$2.52B
$1.91M 0.03%
58,650
-4,655
-7% -$161K
ELGX
89
DELISTED
Endologix Inc
ELGX
$1.91M 0.03%
35,713
-13,620
-28% -$719K
PODD icon
90
Insulet
PODD
$11.8B
$1.91M 0.03%
27,619
-73,464
-73% -$4.82M
HIND
91
Vyome Holdings
HIND
$14M
– –
0
– –
ZVRA icon
92
Zevra Therapeutics
ZVRA
$578M
$1.76M 0.03%
27,221
– –
CHRS icon
93
Coherus Oncology
CHRS
$217M
$1.76M 0.03%
199,854
-39,117
-16% -$419K
CVS icon
94
CVS Health
CVS
$135B
$1.63M 0.02%
22,470
– –
PGR icon
95
Progressive
PGR
$128B
$1.6M 0.02%
28,400
– –
WBA
96
DELISTED
Walgreens Boots Alliance
WBA
$1.38M 0.02%
18,947
– –
FSTX
97
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
$1.38M 0.02%
25,575
-2,225
-8% -$132K
MA icon
98
Mastercard
MA
$498B
$1.33M 0.02%
8,800
-3,500
-28% -$520K
STOR
99
DELISTED
STORE Capital Corporation
STOR
$1.31M 0.02%
50,360
– –
ELV icon
100
Elevance Health
ELV
$81.5B
$1.13M 0.02%
5,000
– –
2 3
4
5 6

Similar funds

ASC
Atalanta Sosnoff Capital New York $4.66B AUM 41.34% 1-Year Est. Return
MA
Mutual Advisors Omaha, Nebraska $4.67B AUM 17.48% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
EI
EFG International Zurich $4.67B AUM
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
VCM
Voleon Capital Management Berkeley, California $4.64B AUM 38.78% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.63B AUM 13.51% 1-Year Est. Return
CCWM
Cassaday & Co Wealth Management Mclean, Virginia $4.69B AUM 20.56% 1-Year Est. Return

C WorldWide Group's Q4 2017 Portfolio in Review

As of Q4 2017, C WorldWide Group held 128 positions worth $6.92B, down 1.7% from $7.04B the previous quarter. Its ten largest holdings account for 74% of the portfolio.

C WorldWide Group withdrew a net $387M in Q4 2017, closing 5 positions and reducing 68 holdings. Its most notable exit was Teva Pharmaceuticals, an estimated $5.74M position sold in full.

By sector, the portfolio is most concentrated in Financials at 31% of assets, up from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

Against the trend, C WorldWide Group opened a new position in Pinnacle Foods, Inc. worth $1.02M.

  • C WorldWide Group's largest Q4 2017 buy was Pinnacle Foods, Inc.: 17,200 shares worth $1.02M.
  • C WorldWide Group added most to Visa in Q4 2017, an estimated $13.6M increase.
  • C WorldWide Group's biggest Q4 2017 reduction was Gilead Sciences, cutting an estimated $300M.
  • C WorldWide Group fully exited Teva Pharmaceuticals in Q4 2017, selling an estimated $5.74M.
  • C WorldWide Group's ten largest holdings make up 74% of its $6.92B portfolio in Q4 2017.
  • C WorldWide Group opened 2 new positions and closed 5 in Q4 2017.
  • C WorldWide Group's portfolio value fell 1.7% quarter-over-quarter to $6.92B.

Based on C WorldWide Group's 13F filing for Q4 2017, filed 7 Feb 2018.